Explore more publications!

Press Releases

Germany Says Ukraine's 2027 EU Entry “Out of the Question”

Germany Says Ukraine's 2027 EU Entry “Out of the Question”

Germany Dismisses 2027 Timeline for Ukraine’s EU Accession

Germany Dismisses 2027 Timeline for Ukraine’s EU Accession

EU Calls for Restraint to Prevent Escalation in Middle East

EU Calls for Restraint to Prevent Escalation in Middle East

Global Market Report on Airport Phone Charging Stations 2026: Business Growth, Development Drivers, Trends Through 2030
U.S. Law Enforcement Assists Bulgarian Law Enforcement in Taking Down Three of the Largest Piracy Sites in The European Union

U.S. Law Enforcement Assists Bulgarian Law Enforcement in Taking Down Three of the Largest Piracy Sites in The European Union

MEP Peter Agius convenes European Parliament Conference with Comply.Land on Cyber Resilience and Digital Trust
Russian Sandworm group attacks energy company in Poland with DynoWiper, ESET Research discovers
Merz Refutes Zelensky’s Demand for 2027 Accession Date to EU

Merz Refutes Zelensky’s Demand for 2027 Accession Date to EU

Macron Calls for Stronger EU Arctic Defense

Macron Calls for Stronger EU Arctic Defense

Merz Rules Out 2027 as Target Date for Ukraine’s EU Accession

Merz Rules Out 2027 as Target Date for Ukraine’s EU Accession

Liberal Pro-EU Party Says Visa should be Revoked from Ex-Australian FM

Liberal Pro-EU Party Says Visa should be Revoked from Ex-Australian FM

Western Firms will Fall Over in Rush to reestablish business in Russia

Western Firms will Fall Over in Rush to reestablish business in Russia

Singapore Crowned World Champion at the Gelato World Cup  in Rimini, Italy
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Italy Showcases UNESCO-Recognised Cuisine as Global Demand Accelerates at Gulfood 2026
Actelis Networks Receives Significant Expansion Order from Major European Natural Gas Operator, Continuing Critical Infrastructure Modernization
Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy
Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
BE IN THE CLOUD Launches New Cloud Backup Solution for Business Data Protection

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions